loader2
NRI

Nov 21, 2024

Category

Equity

AUM (Cr.)

1,187.02

Exit Load (%)

1.00

Min Inv Lumpsum

5,000

Expense Ratio

2.25

Sharpe Ratio

28.41

Beta Ratio

0.00

Fund Manager

Kamal Gada

Inception Date

Jun 28, 1999

Risk Level

Very High

Investment Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Invest Now
Nifty Pharma

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - UTI-Healthcare Fund (G) -2.26 22.81 43.02 19.78 27.15 13.99
Benchmark - Nifty Pharma 15.17 46.96 48.33 9.19 -2.27 0
Category Average - BEST EQUITY PERFORMERS -5.68 5.42 28.95 16.31 21.07 16.05
Category Rank 8/7 7/7 7/7 7/7 7/7 7/7
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
ICICI Pru US Bluechip Equity Fund (IDCW) 63.2300 1.48 21.44 10.22 14.79 3,221.37 1.99 5,000.00 invest
ICICI Pru US Bluechip Equity Fund (G) 63.2300 1.48 21.44 10.22 14.79 3,221.37 1.99 5,000.00 invest
Aditya Birla SL International Equity Fund (IDCW) 16.9448 0.88 14.82 3.92 8.24 182.93 2.54 1,000.00 invest
Aditya Birla SL International Equity Fund (G) 34.8146 0.88 14.83 3.92 8.24 182.93 2.54 1,000.00 invest
Tata Quant Fund - Regular (IDCW) 14.7462 -2.52 16.16 11.33 0.00 67.78 0.00 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Apollo Hospitals Oct 31, 2024 42.14 3.55 -9.67
Equity-Dr Reddy`s Labs Oct 31, 2024 55.49 4.67 -5.64
Equity-Cipla Oct 31, 2024 69.93 5.89 -6.05
Equity-P & G Health Ltd Oct 31, 2024 38.72 3.26 -3.56
Equity-Sun Pharma.Inds. Oct 31, 2024 134.05 11.29 -5.38
Equity-Gland Pharma Oct 31, 2024 43.97 3.70 43.98
Equity-Ajanta Pharma Oct 31, 2024 63.86 5.38 -0.27
Equity-Glenmark Pharma. Oct 31, 2024 42.42 3.57 1.26
Equity-Fortis Health. Oct 31, 2024 39.63 3.34 1.56
Equity-ERIS Lifescience Oct 31, 2024 36.43 3.07 -0.72

latest news

UTI Aggressive Hybrid Fund announces Income Distribution cum Capital Withdrawal (IDCW)

UTI Mutual Fund has announced 26 November 2024 as the record date for decla...

Nov 22, 2024 09:20

UTI Conservative Hybrid Fund announces Income Distribution cum capital withdrawal (IDCW)

UTI Mutual Fund has announced IDCW is 04 November 2024 as the record date f...

Oct 30, 2024 09:20

UTI MF announces Income Distribution cum capital withdrawal (IDCW)

UTI Mutual Fund has announced 22 October 2024 as the record date for the de...

Oct 18, 2024 09:36

UTI MF announces change in benchmark index under its scheme

UTI Mutual Fund has announced change in the benchmark of UTI Floater Fund w...

Oct 03, 2024 11:12

UTI MF announces change in Fund Manager of the following schemes

UTI Mutual Fund has announced change in Fund Managers of the following sche...

Oct 01, 2024 10:24

UTI Mutual Fund announces change in Key Personnel

UTI Mutual Fund has announced that Mr. Santosh Kumar has been appointed as ...

Sep 30, 2024 11:39

SCHEME DETAILS

AMC Name : UTI Mutual Fund
Fund Name : UTI-Healthcare Fund (G)
Contact Persone : Kamal Gada
Registered Address : UTI Towers, Gn Block,Bandra Kurla Complex,Bandra (East), Mumbai 400 051
Telephone No : 022 66786666
Fax No. : 022 66786503;66786578
Email : service:uti.co.in
Website : www.utimf.com